Quantcast
Home / Legal News / Generic drug preemption ruling a blow to plaintiffs

Generic drug preemption ruling a blow to plaintiffs

The U.S. Supreme Court’s decision barring state-law design-defect claims against generic drug makers that mirror failure-to-warn actions served a major setback to plaintiffs seeking damages for drug injuries.

Leave a Reply

Your email address will not be published. Required fields are marked *

*